MedPath

UNIVERSITY OF ARIZONA

UNIVERSITY OF ARIZONA logo
🇺🇸United States
Ownership
Private
Established
1885-01-01
Employees
10K
Market Cap
-
Website
http://www.arizona.edu

Clinical Trials

444

Active:26
Completed:219

Trial Phases

6 Phases

Early Phase 1:16
Phase 1:30
Phase 2:66
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (386 trials with phase data)• Click on a phase to view related trials

Not Applicable
243 (63.0%)
Phase 2
66 (17.1%)
Phase 1
30 (7.8%)
Phase 4
20 (5.2%)
Early Phase 1
16 (4.1%)
Phase 3
11 (2.8%)

Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing Loss

Not Applicable
Not yet recruiting
Conditions
Hearing Aids
Hearing Loss, Bilateral Sensorineural
3D Printing
First Posted Date
2025-11-14
Last Posted Date
2025-11-14
Lead Sponsor
University of Arizona
Target Recruit Count
32
Registration Number
NCT07228845
Locations
🇺🇸

The University of Arizona Hearing Clinic, Tucson, Arizona, United States

NAC-REPAIR for Post-surgical Pain

Not Applicable
Not yet recruiting
Conditions
Carpal Tunnel Surgery
Trigger Finger Disorder
De Quervain Syndrome
Guyon's Canal
Dupuytren Contracture
Morton Neuroma
Tarsal Tunnel Syndrome
Plantar Fasciopathy
Peroneal Nerve Entrapment
Interventions
First Posted Date
2025-11-13
Last Posted Date
2025-11-14
Lead Sponsor
University of Arizona
Target Recruit Count
80
Registration Number
NCT07227649
Locations
🇺🇸

Banner Health, Tucson, Arizona, United States

Effectiveness Comparison of 3D-Printed and Conventional Ear Tip Comfort in Individuals With Hearing in the Normal Range

Not Applicable
Recruiting
Conditions
Hearing Aids
3D Printing
First Posted Date
2025-10-15
Last Posted Date
2025-11-10
Lead Sponsor
University of Arizona
Target Recruit Count
30
Registration Number
NCT07216937
Locations
🇺🇸

The University of Arizona Hearing Clinic, Tucson, Arizona, United States

The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer

Not Applicable
Not yet recruiting
Conditions
Lung Cancer - Non Small Cell
First Posted Date
2025-10-14
Last Posted Date
2025-10-22
Lead Sponsor
University of Arizona
Target Recruit Count
48
Registration Number
NCT07216209
Locations
🇺🇸

University of Arizona Cancer Center, Tucson, Arizona, United States

Human Papillomavirus (HPV) Self-Sampling Options to Promote Equity

Not Applicable
Not yet recruiting
Conditions
Uterine Cervical Neoplasms
HPV Testing
Pap Smear
First Posted Date
2025-10-09
Last Posted Date
2025-10-29
Lead Sponsor
University of Arizona
Target Recruit Count
100
Registration Number
NCT07214506
Locations
🇺🇸

El Rio Santa Cruz Neighborhood Health, Tucson, Arizona, United States

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 89
  • Next

News

Early Hormone Therapy Reduces Alzheimer's Risk by 32% in Postmenopausal Women, New Meta-Analysis Shows

A comprehensive meta-analysis of 53 studies involving over 8.4 million postmenopausal women found that starting hormone replacement therapy within five years of menopause onset reduces Alzheimer's disease risk by 32%.

Novel Nanoparticle Formulations Enhance Paclitaxel Delivery to Cancer Tumors

University of Arizona researchers developed Paclitaxome, a new nanovesicle formulation of paclitaxel that outperformed standard chemotherapy drugs Taxol and Abraxane in mouse models of triple-negative breast cancer and advanced pancreatic cancer.

Octapharma's PANZYGA Shows Mixed Results in Phase 3 PANS Trial, Achieves Significant Secondary Endpoint

Octapharma's phase 3 trial of PANZYGA for pediatric acute-onset neuropsychiatric syndrome (PANS) missed its primary endpoint of reducing obsessive-compulsive symptoms measured by CY-BOCS score.

Ketamine Shows Promise in Restoring Motor Control in Parkinson's Patients with Dyskinesia

Researchers have discovered that levodopa-induced dyskinesia in Parkinson's patients involves a functional disconnection of the motor cortex from movement control.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.